- KR₩2tn
- KR₩2tn
- KR₩274bn
- 46
- 11
- 24
- 13
Annual income statement for ST Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 124,109 | 165,642 | 249,322 | 284,992 | 273,751 |
| Cost of Revenue | |||||
| Gross Profit | 19,985 | 57,743 | 88,932 | 112,115 | 96,163 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 142,924 | 160,064 | 231,469 | 251,533 | 246,201 |
| Operating Profit | -18,815 | 5,578 | 17,852 | 33,459 | 27,550 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16,825 | 1,260 | 19,237 | 23,354 | 42,747 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13,155 | 3,377 | 17,516 | 17,523 | 32,464 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -12,147 | 3,312 | 18,000 | 19,581 | 34,712 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -12,147 | 3,312 | 18,000 | 19,581 | 34,712 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -651 | 305 | 988 | 1,043 | 1,842 |
| Dividends per Share |